Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fatak Chemie Pars (FCP) is an Iranian pharmaceutical company specializing in the development and production of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 2003, the company operates a manufacturing facility in the Eshtehard Industrial Town that complies with international Good Manufacturing Practice (GMP) standards. FCP's product portfolio primarily focuses on generic small molecule therapeutics for chronic conditions, including diabetes, epilepsy, and cardiovascular diseases. The company serves as both a manufacturer of finished drugs and a supplier of chemical raw materials for the broader pharmaceutical industry in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fatak Chemie Pars Pharmacy.